roflumilast
Wed, 04 Jan 2023 10:03:32 -0500
ZORYVE™ (crème de roflumilast, 0,3 %) est indiqué dans le traitement topique du psoriasis en plaques, notamment dans les régions intertrigineuses, chez le patient de 12 ans ou plus.
Italiano
Wed, 04 Jan 2023 10:03:32 -0500
ZORYVE™ (crème de roflumilast, 0,3 %) est indiqué dans le traitement topique du psoriasis en plaques, notamment dans les régions intertrigineuses, chez le patient de 12 ans ou plus.
Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # R2200232 Exp: 01/2025 to the consumer/user level.
Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin Hydrochloride Injection, USP, 1.5 g/vial Single Dose Flip-top Vial, lot 33045BA, to the user level due to two visible glass particulates observed in a single vial.
Xiamen, Fujian, GFA Production (Xiamen) Co., Ltd. is voluntarily recalling one lot of Easy Care first aid® AfterBurn® Cream, 0.9 g single-use packets. The single use packets are sold in boxes of 10 or packaged in certain First Aid kits. This recall is to the consumer level. FDA analysis found the p
Fri, 23 Dec 2022 13:03:17 -0500
Fri, 23 Dec 2022 13:03:16 -0500
Fri, 23 Dec 2022 13:03:16 -0500
Fri, 23 Dec 2022 13:03:14 -0500
Fri, 23 Dec 2022 13:03:12 -0500
Fri, 23 Dec 2022 13:03:03 -0500
80.211.154.110